Literature DB >> 15253741

Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients.

Makoto Anraku1, Kenichiro Kitamura, Ayumi Shinohara, Masataka Adachi, Ayaka Suenga, Toru Maruyama, Kei Miyanaka, Taku Miyoshi, Naoki Shiraishi, Hiroshi Nonoguchi, Masaki Otagiri, Kimio Tomita, Ayaka Suenaga.   

Abstract

BACKGROUND: Intravenous iron administration (IVIR) is effective for correcting anemia in hemodialysis (HD) patients. However, it may also enhance the generation of hydroxyl radicals. Recently, plasma proteins have been demonstrated to be extremely susceptible to oxidative stress. Therefore, we investigated the effect of IVIR on the oxidative status of albumin, a major plasma protein, in HD patients.
METHODS: Eleven hemodialysis (HD) patients were treated with 40 mg of saccharated ferric oxide intravenously after every dialysis session for four weeks, and 11 age-/gender-matched HD patients were treated with vehicle. We performed high performance liquid chromatography (HPLC) analysis of serum albumin and determined the levels of reduced and oxidized albumin. Carbonyl formation of plasma proteins were also measured using an anti-2,4 dinitrophenylhydrazine antibody in patients with or without IVIR.
RESULTS: IVIR resulted in an increase in both disulfide form (f(HNA-1)) and oxidized form (f(HNA-2)) of albumin in HD patients (36.0 +/- 6.03 vs. 41.7 +/- 6.27; 5.46 +/- 1.50 vs. 8.7 +/- 2.22, respectively, P < 0.05). The findings here also show that IVIR substantially increased plasma protein carbonyl content by oxidizing albumin. In addition, we found a strong correlation between plasma carbonyl content and the levels of oxidized albumin (f(HNA-1) and f(HNA-2)) in HD patients (R= 0.674 and R= 0.724, respectively, P < 0.01).
CONCLUSION: The results of this study indicate that the HPLC analysis of serum albumin represents a potentially useful method for the quantitative and qualitative evaluation of oxidative stress in HD patients, and strongly suggest the possibility that oxidative stress, generated by IVIR, enhances the oxidation of albumin in those patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15253741     DOI: 10.1111/j.1523-1755.2004.00813.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  17 in total

Review 1.  Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.

Authors:  K Oettl; R E Stauber
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

Review 2.  The Labile Side of Iron Supplementation in CKD.

Authors:  Itzchak Slotki; Zvi Ioav Cabantchik
Journal:  J Am Soc Nephrol       Date:  2015-05-21       Impact factor: 10.121

3.  Iron, oxidative stress, and clinical outcomes.

Authors:  Rajiv Agarwal
Journal:  Pediatr Nephrol       Date:  2007-11-21       Impact factor: 3.714

4.  An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure.

Authors:  Kazuki Shimoishi; Makoto Anraku; Kenichiro Kitamura; Yuka Tasaki; Kazuaki Taguchi; Mitsuru Hashimoto; Eiko Fukunaga; Toru Maruyama; Masaki Otagiri
Journal:  Pharm Res       Date:  2007-03-27       Impact factor: 4.580

Review 5.  Iron therapy for renal anemia: how much needed, how much harmful?

Authors:  Walter H Hörl
Journal:  Pediatr Nephrol       Date:  2007-01-06       Impact factor: 3.714

6.  Continuous Reduction of Protein-Bound Uraemic Toxins with Improved Oxidative Stress by Using the Oral Charcoal Adsorbent AST-120 in Haemodialysis Patients.

Authors:  Suguru Yamamoto; Junichiro J Kazama; Kentaro Omori; Koji Matsuo; Yoshimitsu Takahashi; Kazuko Kawamura; Takayuki Matsuto; Hiroshi Watanabe; Toru Maruyama; Ichiei Narita
Journal:  Sci Rep       Date:  2015-09-23       Impact factor: 4.379

7.  Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseases.

Authors:  Kohei Nagumo; Motohiko Tanaka; Victor Tuan Giam Chuang; Hiroko Setoyama; Hiroshi Watanabe; Naoyuki Yamada; Kazuyuki Kubota; Motoko Tanaka; Kazutaka Matsushita; Akira Yoshida; Hideaki Jinnouchi; Makoto Anraku; Daisuke Kadowaki; Yu Ishima; Yutaka Sasaki; Masaki Otagiri; Toru Maruyama
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

8.  N-acetyl-L-methionine is a superior protectant of human serum albumin against post-translational oxidation as compared to N-acetyl-L-tryptophan.

Authors:  Yousuke Kouno; Makoto Anraku; Keishi Yamasaki; Yoshiro Okayama; Daisuke Iohara; Hedeaki Nakamura; Toru Maruyama; Fumitoshi Hirayama; Ulrich Kragh-Hansen; Masaki Otagiri
Journal:  Biochem Biophys Rep       Date:  2016-04-26

9.  Effects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype.

Authors:  Zaher Armaly; Amir Abd El Qader; Adel Jabbour; Kamal Hassan; Rawi Ramadan; Abdalla Bowirrat; Bishara Bisharat
Journal:  BMC Nephrol       Date:  2015-08-13       Impact factor: 2.388

Review 10.  Systemic Redox Imbalance in Chronic Kidney Disease: A Systematic Review.

Authors:  Konstantina P Poulianiti; Antonia Kaltsatou; Georgia I Mitrou; Athanasios Z Jamurtas; Yiannis Koutedakis; Maria Maridaki; Ioannis Stefanidis; Giorgos K Sakkas; Christina Karatzaferi
Journal:  Oxid Med Cell Longev       Date:  2016-08-03       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.